Search JIC Articles:
The Official Journal of the International Andreas Gruentzig Society
Friday, May 16, 2008


text size: A A A
manuscripts: submit | review

Valve Replacement

Surgical valve replacement remains the definitive therapy for valvular heart disease in patients who are suitable candidates for the surgery, but percutaneous insertion of pulmonic and aortic valves is in the early stages of clinical evaluation. Less than 100 patients have been successfully treated with the percutaneous insertion of a stent-based pulmonic valve to treat conduit stenosis. Balloon aortic valvuloplasty, which is generally used as a temporary therapy leading up to surgical valve replacement, has not enjoyed much success. Thus, small numbers of high-risk patients have now undergone percutaneous placement of prosthetic aortic valves, with somewhat discouraging morbidity and mortality rates. There are no currently-approved percutaneous valve devices in the U.S.

Transcatheter Closure of Acquired Gerbode Defect following Mitral Valve Replacement Using the Amplatzer Duct Occluder
Transcatheter Closure of Acquired Gerbode Defect following Mitral Valve Replacement Using the Amplatzer Duct Occluder CASE REPORTS: Transcatheter Closure of Acquired Gerbode Defect following Mitral Valve Replacement Using the Amplatzer Duct Occluder - Avraham Lorber, MD, Prashant Nair, MD, Luis Gruberg, MD Left ventricular-to-right atrial communications are rare types of ventricular septal defects known collectively as the Gerbode defect.1 Acquired ...



Current Results of Balloon Aortic Valvuloplasty in High-Risk Patients
ABSTRACT: In this report, we describe our experience with a contemporary series of patients with severe aortic stenosis (AS) undergoing balloon aortic valvuloplasty (BAV) who were not deemed to be surgical candidates. Demographic, hemodynamic and procedural data, operative risk (EuroSCORE) and long-term follow up were collected. Eighty consecutive patients with severe symptomatic AS underwent 104 BAV procedures as a single center and were followed for a mean of 3 ± 2 years. Thirteen patients underwent 2 BAV procedures, 2 patients underwent 3 BAV procedures and 1 patient underwent 5 BAV procedures. Mean age was 81 ± 10 years, and 23% were > 90 years of age. Cardiogenic shock was present in 20% and the ejection fraction was < 30% in 38% of the patients. The mean EuroSCORE was 16 ± 5, and 98% had a high-risk EuroSCORE. There were no procedural deaths and 9 (9%) total vascular complications. In-hospital, 1-, 2- and 3-year mortality rates were 6%, 44%, 62% and 71%, respectively. Seventeen patients (21%) underwent repeat BAV procedures and had long-term mortality similar to those undergoing a single BAV procedure. Contemporary BAV has acceptable short- and long-term results and can effectively be used for patients deemed unsuitable surgical candidates and those at highest operative risk, such as patients with cardiogenic shock.



Kugel?s Artery Arising from an Anomalous Left Circumflex Coronary Artery
ABSTRACT: In the modern surgical era, postoperative prosthetic valve endocarditis persists as a potentially devastating complication of valve replacement surgery. While generally resulting in valvular destruction and regurgitation, prosthetic valve endocarditis may also result in valvular obstruction. The diagnosis of prosthetic valve endocarditis may be difficult due to technical limitations affecting the diagnostic capability of transthoracic echocardiography in patients with prosthetic valves and the indolent nature of the infectious process. We describe the first reported case of Aspergillus endocarditis leading to obstruction of a prosthetic valve in a patient with recent aortic valve replacement.



Intravascular Ultrasound Imaging and Percutaneous Intervention in a Patient with Post-Mitral Valve Replacement Circumflex Coronary Artery Occlusion
Intravascular Ultrasound Imaging and Percutaneous Intervention in a Patient with Post-Mitral Valve Replacement Circumflex Coronary Artery Occlusion CASE REPORTS: Intravascular Ultrasound Imaging and Percutaneous Intervention in a Patient with Post-Mitral Valve Replacement Circumflex Coronary Artery Occlusion - Rajbir Sangha, MB ChB and Peter Hui, MD Iatrogenic damage to coronary arteries is a previously described, but uncommon, complication of mitral valve surgery. Mitral valve repair/...



First Human Case Description of TandemHeart?-Assisted High-Risk Percutaneous Balloon Aortic Valvuloplasty Using Bivalirudin Anticoagulation
ABSTRACT: TandemHeart? is a recently-introduced percutaneous left ventricular assist device that can be used for hemodynamic support during high-risk interventional procedures in severely compromised patients. Angioplasty and stent placement in patients with coronary artery disease and high-risk coronary anatomy including the left main coronary artery have been described using this device. We report the first human case description of a high-risk percutaneous balloon aortic valvuloplasty for critical bicuspid aortic stenosis using the TandemHeart for periprocedural hemodynamic support. Also not previously reported is the use of bivaluridin as the periprocedural antithrombin agent during and after high-risk aortic valvuloplasty.



uccessful Bailout Percutaneous Coronary Intervention for Immediate Surgical Complication
This case report describes a 36-year-old male with acute complete occlusion of his dominant left circumflex coronary artery after mechanical mitral valve replacement. The patient was successfully treated with percutaneous catheter intervention using drug-eluting coronary stents.



Black Aorta: A Rare Finding at Aortic Valve Replacement
Black Aorta: A Rare Finding at Aortic Valve Replacement Case Report and Brief Review: Black Aorta: A Rare Finding at Aortic Valve Replacement - Ross J. Goodfellow, DO, Jeffrey Schwartz, MD, Ferdinand Leya, MD Case report. At catheterization, the patient was found to have severe left main and three-vessel coronary disease. A recently published study analyzed the ...



Use of a Thrombus Extraction Catheter (Pronto®) in the Treatment of Acute Myocardial Infarction after Coronary Embolism Post Mitral Valve Replacement
Case Report. TEE revealed a normal-functioning St. Jude mechanical prosthesis. The Pronto catheter is contraindicated in vessels We present a report of the Pronto catheter used to treat coronary embolism.



Bilateral Coronary Ostial Stenoses Post-Bentall Procedure: Management Options in the DES Era
The Bentall procedure for aortic root and valve replacement with coronary reimplantation was initially described in 1968.1 This procedure is considered the ?gold standard? for treatment of combined valve and ascending aortic pathology. The procedure is performed most commonly in patients with degenerative aortic disease, including atherosclerotic disease, ectasia and poststenotic aortic dilatation.2,3 The complication of single coronary ostial stenosis following reimplantation is extremely rare in this procedure, occurring in less than 2% of patients.4,5 We describe the first case of bilateral coronary ostial stenoses following the Bentall procedure in a patient with documented heparin-induced thrombocytopenia (HIT) that was successfully treated with percutaneous coronary intervention (PCI).



Large Mitral Annular Left Ventricular Pseudoaneurysm Detected by Cardiac Magnetic Resonance Imaging
Although left ventricular pseudoaneurysm (LVPA) is a rare complication of mitral valve replacement, it is associated with an increased risk of rupture and consequent high mortality. It is important to establish the diagnosis of LVPA early so that definitive surgical therapy can be administered. Cardiac magnetic resonance imaging provides an accurate preoperative evaluation that may be useful in the routine evaluation of suspected LVPA cases. J INVASIVE CARDIOL 2007;19:88?89



Electrophysiologic Perspective on the BIPOLAR RF EPICARDIAL ABLATION Procedure for Atrial Fibrillation

Complimentary Accredited Breakfast Symposium

Click Here for More Info.

Location: The St. Regis San Francisco
125 3rd Street
San Francisco, CA 94103
3rd and Mission Streets
Gallery Ballroom, 2nd floor


This activity is supported by an educational grant from AtriCure, Inc.

This program is not part of the Heart Rhythm 2008 Official Scientific Sessions as planned by the Heart Rhythm Society Scientific Sessions Committee. This event is neither sponsored nor endorsed by the Heart Rhythm Society.
Newest Perspectives on Drug-Eluting Stents

Complimentary CME Accredited Dinner Meetings Click Here for More Info.



Miami, FL - Date: Friday, April 4, 2008 6:00pm EST -8:00 pm EST

Birmingham, AL - Date: Friday, May 9, 2008 6:00pm EST -8:00 pm EST

This activity is supported by an educational grant from Abbott Vascular.
CLINICAL EXPERIENCE WITH A NEW HYBRID CORONARY WIRE

On Demand Web Archive
Non-Accredited


This activity is supported by an educational grant from Terumo Medical Corporation.
Pharmacoinvasive Management of Acute Coronary Syndrome: Incorporating the 2007 ACC/AHA Guidelines

Complimentary Accredited CME Program

This activity is supported by an educational grant from Sanofi-Aventis.
Varicose Veins: Causes, Symptoms, Diagnosis and Treatment of Chronic Venous Insufficiency

A Complimentary Accredited ON-DEMAND Webcast

This activity is supported by an educational grant from Diomed, Inc.


Antiplatelet Strategies in the DES Era

A Complimentary Accredited ON-DEMAND Webcast

This activity is supported by an educational grant from Bristol-Myers Squibb/Sanofi Pharmaceuticals.

Create a Successful Vena Cava Filter Practice

Accredited CD

This activity is supported by an educational grant from Cook Incorporated and has been designed for Interventional Cardiologists, Vascular Surgeons, Fellows and Interventional Cardiovascular Nurses and Technologists.


Webcast and Web Archives

Frontiers in 3D Imaging: Role in Today's Electrophysiology Practice

Complimentary Accredited Web Archive - On-Demand

Learning objectives
1. discuss the concept of CT overlay on fluoroscopic images
2. describe the limitations of CT overlay

This activity has been developed for physicians.

Achieving Optimal Outcomes in Carotid Stenting: Lessons Learned from Recent Clinical Trials
Complimentary Accredited ON DEMAND Webcast

Topics
1. EVA-3S & Space-Bumps in the road
2. CAPTURE 3500-Lesion morphology & Predictors for Stroke
3. CAPTURE II vs. EXACT 1500-Does open or Closed Cell Stent design really matter?

This activity has been developed for Interventional Cardiologists, Vascular Surgeons, Interventional Radiologists, Neurologists, Interventional Nurses and Technologists with an interest in the diagnosis and treatment of peripheral artery disease.

Anticoagulation Techniques for Peripheral Vascular Interventions

Complimentary Accredited ON DEMAND Webcast

This activity has been developed for Interventional Cardiologists, Vascular Surgeons, Interventional Radiologists, Podiatric Physicians, Endovascular Allied Professionals, Endocrinologists, Wound Care Specialists, Directors of the Wound Care Clinic, and Primary Care Physicians, Pharmacists, Nurses and Technologists.

New Treatment Strategies for the Endovascular Approach to Critical Limb Ischemia: ADVANCEMENTS IN LIMB SALVAGE MEDICINE
Complimentary Accredited ON DEMAND Webcast

This activity has been developed for Interventional Cardiologists, Vascular Surgeons, Interventional Radiologists, Podiatric Physicians, Endovascular Allied Professionals, Endocrinologists, Wound Care Specialists, Directors of the Wound Care Clinic, and Primary Care Physicians, Pharmacists, Nurses and Technologists.


CT Angiography: Current & Future Trends in Cardiac Imaging

Complimentary CME/CEU
ON DEMANDWebcast Archive

This educational activity has been developed for physicians, nurses and technologists.




Evidence-Based Approach to Atrial Fibrillation

Complimentary CME/CEU
ON DEMAND Webcast Archive

Topics: Ablation of PAF: Risks, Benefits and Outcomes, Chronic AF: The Last Frontier, Randomized Trials of AF Ablation, New AF Guidelines: Where does Ablation fit in?



Reducing the Incidence of CIN during Cardiac Catheterization and PCI

Complimentary Accredited ON DEMAND
Educational Web Archive

This activity has been developed for nurses and technologists.

March 2007 Supplement
On-Demand Webcast
Archived Webcast
© 2008 HMP Communications | All Rights Reserved
83 General Warren Blvd, Suite 100 | Malvern, PA 19355 | 800.237.7285